NCT00215345View on ClinicalTrials.gov

A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

December 31, 2006

Conditions
Prostate Cancer
Interventions
DRUG

Taxotere

DRUG

Celecoxib

Trial Locations (1)

07018

RECRUITING

Department Of Veterans Affairs NJ Health Care System, East Orange

Sponsors

Collaborators (2)

Pfizer
Sanofi
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

Sanofi

INDUSTRY

lead

Department of Veterans Affairs, New Jersey

FED